Literature DB >> 32482649

Association Between Centromere- and Topoisomerase-specific Immune Responses and the Degree of Microangiopathy in Systemic Sclerosis.

Nina M van Leeuwen1, Corrie M Wortel2, Cynthia M Fehres2, Jaap A Bakker3, Hans U Scherer2, René E M Toes2, Tom W J Huizinga2, Jeska K de Vries-Bouwstra2.   

Abstract

OBJECTIVE: Autoreactive antibody responses, including the use of several isotypes of autoantibodies, have been shown to be associated with clinical outcome in several rheumatic autoimmune diseases. The goals of this study were to evaluate whether (1) anticentromere antibody (ACA)- and antitopoisomerase antibody (ATA)-specific isotype expression, and (2) organ involvement are associated with the degree of microangiopathy in systemic sclerosis (SSc).
METHODS: ACA and ATA IgG, IgM, and IgA levels were measured in baseline serum samples of ACA IgG-positive (+) and ATA IgG+ patients with SSc. The degree of microangiopathy was determined based on nailfold videocapillaroscopy (NVC) images collected at the same point in time. Logistic regression analyses with autoantibodies, clinical characteristics, isotype expression, and ACA and ATA IgG, IgM, and IgA levels as independent variables, and NVC pattern as the dependent variable were performed.
RESULTS: In 164 patients, isotype levels and degree of microangiopathy were evaluated. Logistic regression confirmed the association of the degree of microangiopathy with the presence of digital ulcers (OR 3.07, 95% CI 1.43-6.60), interstitial lung disease (OR 3.41, 95% CI 1.11-10.61), and pulmonary arterial hypertension (OR 5.58, 95% CI 2.05-17.81). ATA positivity was associated with more severe microangiopathy (OR 2.09, 95% CI 1.05-4.13). Patients who expressed solely ACA IgG showed a trend towards less severe microangiopathy compared to patients also expressing ACA IgM and/or IgA. Levels of ACA IgG and ATA IgM were found to be associated with microangiopathy severity.
CONCLUSION: We observed an association between ACA and ATA responses and the degree of microangiopathy in SSc. These findings might indicate that the breadth of the autoimmune response, as reflected by autoantibody production and microvascular damage, interacts in the pathophysiology of SSc.
Copyright © 2021 by the Journal of Rheumatology.

Entities:  

Keywords:  autoantibodies; microangiopathy; pathophysiology; systemic sclerosis

Year:  2020        PMID: 32482649     DOI: 10.3899/jrheum.191331

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis.

Authors:  Nina M van Leeuwen; Maaike Boonstra; Jaap A Bakker; Annette Grummels; Suzana Jordan; Sophie Liem; Oliver Distler; Anna-Maria Hoffmann-Vold; Karin Melsens; Vanessa Smith; Marie-Elise Truchetet; Hans U Scherer; René Toes; Tom W J Huizinga; Jeska K de Vries-Bouwstra
Journal:  Arthritis Rheumatol       Date:  2021-11-02       Impact factor: 15.483

2.  Capillaroscopy and Immunological Profile in Systemic Sclerosis.

Authors:  Sevdalina Nikolova Lambova; Ekaterina Krasimirova Kurteva; Sanie Syuleymanova Dzhambazova; Georgi Hristov Vasilev; Dobroslav Stanimirov Kyurkchiev; Mariela Gencheva Geneva-Popova
Journal:  Life (Basel)       Date:  2022-03-29

Review 3.  Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?

Authors:  Aurélien Chepy; Louisa Bourel; Vincent Koether; David Launay; Sylvain Dubucquoi; Vincent Sobanski
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

4.  Clinical significance of serum ferritin in patients with systemic sclerosis.

Authors:  Yanting Jiang; Xi Li; Wei Zhou; Min Jin; Sihui Li; Yuehong Lao; Haiqing Zhu; Jian Wang
Journal:  J Clin Lab Anal       Date:  2022-07-09       Impact factor: 3.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.